The French researchers who killed a participant in their clinical trial "did not use common sense" and, to those of those who are familiar with the careful, slow escalation of the Kevetrin trial, shockingly escalated the dosages by DOUBLING them. Unbelievable that anyone could think that this was a logical way to run a clinical trial.

I am as always grateful for the careful work of the CTIX team, which is concerned about patient safety, and does not take crazy risks in the clinical trials.

http://www.fiercebiotech.com/cro/%E2%80%98tox...e=internal